| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticoagulation in Acute Coronary Syndrome-State of the Art
|
Zeitouni, Michel
|
|
2018
|
60 |
4-5 |
p. 508-513
|
artikel
|
| 2 |
Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease in Adults 80-Years-of-Age and Older
|
Sarbacker, G. Blair
|
|
2018
|
60 |
4-5 |
p. 562-564
|
artikel
|
| 3 |
Clinical Implications of Technological Advances in Screening for Atrial Fibrillation
|
Singh, Nikhil
|
|
2018
|
60 |
4-5 |
p. 550-559
|
artikel
|
| 4 |
Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists
|
Chen, Sean T.
|
|
2018
|
60 |
4-5 |
p. 514-523
|
artikel
|
| 5 |
Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy – “Real World” Experience
|
Effron, Mark B.
|
|
2018
|
60 |
4-5 |
p. 531-536
|
artikel
|
| 6 |
Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Sharma, Abhishek
|
|
2018
|
60 |
4-5 |
p. 500-507
|
artikel
|
| 7 |
Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician
|
Vidula, Mahesh K.
|
|
2018
|
60 |
4-5 |
p. 491-499
|
artikel
|
| 8 |
Editorial Board
|
|
|
2018
|
60 |
4-5 |
p. A4
|
artikel
|
| 9 |
Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
|
Moon, Jae Youn
|
|
2018
|
60 |
4-5 |
p. 478-490
|
artikel
|
| 10 |
Four Years as Editor-in-Chief
|
Lavie, Carl J.
|
|
2018
|
60 |
4-5 |
p. 560-561
|
artikel
|
| 11 |
List of recent issues
|
|
|
2018
|
60 |
4-5 |
p. A3
|
artikel
|
| 12 |
Masthead
|
|
|
2018
|
60 |
4-5 |
p. IFC
|
artikel
|
| 13 |
Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation
|
Miyazawa, Kazuo
|
|
2018
|
60 |
4-5 |
p. 537-541
|
artikel
|
| 14 |
Safety and Efficacy of Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation
|
Price, Matthew J.
|
|
2018
|
60 |
4-5 |
p. 542-549
|
artikel
|
| 15 |
Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
|
Tantry, Udaya S.
|
|
2018
|
60 |
4-5 |
p. 460-470
|
artikel
|
| 16 |
Table of contents
|
|
|
2018
|
60 |
4-5 |
p. A1-A2
|
artikel
|
| 17 |
The Timing of P2Y12 Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?
|
Golwala, Harsh
|
|
2018
|
60 |
4-5 |
p. 471-477
|
artikel
|
| 18 |
The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease – Where Is the Moon Now?
|
Effron, Mark B.
|
|
2018
|
60 |
4-5 |
p. 457-459
|
artikel
|
| 19 |
Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
|
Kerneis, Mathieu
|
|
2018
|
60 |
4-5 |
p. 524-530
|
artikel
|
Tijdschrift beschrijving